Keyphrases
Overexpression
100%
Vaccine Effectiveness
100%
Fusion Protein
100%
Recombinant BCG
100%
Mycobacterium Ulcerans
100%
Buruli Ulcer
100%
Ag85B
100%
Ag85A
35%
BCG Vaccine
28%
Vaccination
14%
Vaccine Design
14%
Survival Time
14%
Immunogenicity Assessment
14%
Overexpressing
7%
Protection Level
7%
Recombinant
7%
Vaccine Candidate
7%
CD4+ T Cells
7%
Tissue Damage
7%
Long-term Survival
7%
Orthologs
7%
Antimycobacterial Activity
7%
Tuberculosis
7%
Post-infection
7%
Prime-boost
7%
Bacterial Burden
7%
Splenocytes
7%
Mycobacterium Bovis BCG
7%
Humoral Response
7%
Recombinant Antigen
7%
Subcutaneous Vaccination
7%
Recombinant Expression
7%
Fusion Vaccine
7%
Tuberculosis Treatment
7%
Recombinant BCG Vaccine
7%
Transient Protection
7%
Ag85
7%
TB10.4
7%
BCG Strain
7%
Immunogenic Antigens
7%
Immunology and Microbiology
Vaccine Efficacy
100%
Mycobacterium Bovis BCG
100%
Mycobacterium ulcerans
100%
BCG Vaccine
28%
Survival Time
14%
Humoral Immunity
7%
Immunogenicity
7%
T-Helper Cell
7%
Bacterial Load
7%
Face
7%
Splenocyte
7%
Orthology
7%
Recombinant Antigen
7%
Infection
7%